Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma
Leukemia and Lymphoma, Volume 62, No. 8, Year 2021
Notification
URL copied to clipboard!
We demonstrate the prognostic utility of antigen quantitation in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and monoclonal B-cell lymphocytosis (MBL). Median antibody-bound-per-cell (ABC) of CD20, CD22, CD25, CD19, and %CD38(+) was determined in CLL (185/208), SLL (8/208) and MBL (15/208) cases by flow cytometry, then compared to Dohner-classification, immunoglobulin status (mutated, IGHV-M; unmutated, IGHV-U), CLL-IPI risk and time to first treatment (TTFT). Trisomy 12 cases showed increased %CD38-expression (p =.0379). Higher %CD38 was observed in IGHV-U versus IGHV-M (p =.0003). CD20ABC was increased in IGHV-U versus IGHV-M (p =.006). Del13q cases demonstrated lower CD22ABC (p =.0198). Cases without cytogenetic abnormality exhibited higher CD19ABC (p =.0295) and CD22ABC (p =.0078). Del17p cases demonstrated lower CD25ABC (p =.0097). High and very-high CLL-IPI risk groups were associated with high CD38-expression (p =.02) and low CD25ABC (p =.0004). Shortened TTFT was associated with high CD38-expression (p <.0001). Interestingly, high CD25ABC trended toward shortened TTFT (p =.07). Quantitative antigen expression reflects CLL-IPI risk groups and Dohner-classification.